BRD9 is a component of the SWI/SNF chromatin remodeling complex, and its degradation disrupts oncogenic transcriptional programs in synovial sarcoma cells, presenting a novel therapeutic avenue [9]. This evidence concerns the gene BRD9 and synovial sarcoma.